These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18790611)

  • 1. In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan).
    Panagopoulos P; Tsaganos T; Plachouras D; Carrer DP; Papadopoulos A; Giamarellou H; Kanellakopoulou K
    Int J Antimicrob Agents; 2008 Dec; 32(6):485-7. PubMed ID: 18790611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro elution of daptomycin by a synthetic crystallic semihydrate form of calcium sulfate, stimulan.
    Kanellakopoulou K; Panagopoulos P; Giannitsioti E; Tsaganos T; Carrer DP; Efstathopoulos N; Giamarellos-Bourboulis EJ
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3106-7. PubMed ID: 19398646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study.
    Kanellakopoulou K; Tsaganos T; Athanassiou K; Koutoukas P; Raftogiannis M; Skiadas I; Giamarellou H
    Int J Antimicrob Agents; 2006 Sep; 28(3):217-20. PubMed ID: 16904297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro elution of moxifloxacin from cancellous bone allografts.
    Kanellakopoulou K; Sahinides T; Tsaganos T; Galanakis N; Giamarellou H; Giamarellos-Bourboulis EJ
    J Biomed Mater Res A; 2010 Jan; 92(1):52-5. PubMed ID: 19165791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
    Kanellakopoulou K; Galanopoulos I; Soranoglou V; Tsaganos T; Tziortzioti V; Maris I; Papalois A; Giamarellou H; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2009 Apr; 33(4):354-9. PubMed ID: 19097865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro release of fusidic acid and teicoplanin from cancellous bone allografts.
    Kanellakopoulou K; Sahinides T; Tsaganos T; Galanakis N; Giamarellou H; Giamarellos-Bourboulis EJ
    J Chemother; 2008 Oct; 20(5):645-7. PubMed ID: 19028629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G; O'Brien TP
    Clin Ther; 2008 Nov; 30(11):2005-14. PubMed ID: 19108788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations.
    Motwani SK; Chopra S; Ahmad FJ; Khar RK
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Oct; 68(2):250-6. PubMed ID: 17329154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).
    Fernández-Varón E; Marín P; Espuny A; Villamayor L; Escudero E; Cárceles C
    J Clin Pharm Ther; 2006 Dec; 31(6):641-3. PubMed ID: 17176370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute.
    Grimsrud C; Raven R; Fothergill AW; Kim HT
    Orthopedics; 2011 Aug; 34(8):e378-81. PubMed ID: 21815580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections.
    Rauschmann MA; Wichelhaus TA; Stirnal V; Dingeldein E; Zichner L; Schnettler R; Alt V
    Biomaterials; 2005 May; 26(15):2677-84. PubMed ID: 15585271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery.
    Metallidis S; Charokopos N; Nikolaidis J; Alexiadou E; Lazaraki G; Koumentaki E; Tsona A; Theodoridis G; Nikolaidis P
    Int J Antimicrob Agents; 2006 Nov; 28(5):428-32. PubMed ID: 17034992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro tobramycin elution analysis from a novel beta-tricalcium phosphate-silicate-xerogel biodegradable drug-delivery system.
    DiCicco M; Goldfinger A; Guirand F; Abdullah A; Jansen SA
    J Biomed Mater Res B Appl Biomater; 2004 Jul; 70(1):1-20. PubMed ID: 15199578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
    Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
    Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma.
    Hemanth Kumar AK; Ramachandran G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1205-8. PubMed ID: 19286427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protonation equilibrium and lipophilicity of moxifloxacin.
    Langlois MH; Montagut M; Dubost JP; Grellet J; Saux MC
    J Pharm Biomed Anal; 2005 Feb; 37(2):389-93. PubMed ID: 15708683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC.
    Djurdjevic P; Ciric A; Djurdjevic A; Stankov MJ
    J Pharm Biomed Anal; 2009 Sep; 50(2):117-26. PubMed ID: 19464135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitated permeation of antibiotics across membrane channels--interaction of the quinolone moxifloxacin with the OmpF channel.
    Mach T; Neves P; Spiga E; Weingart H; Winterhalter M; Ruggerone P; Ceccarelli M; Gameiro P
    J Am Chem Soc; 2008 Oct; 130(40):13301-9. PubMed ID: 18788798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers.
    Wagenlehner FM; Kees F; Weidner W; Wagenlehner C; Naber KG
    Int J Antimicrob Agents; 2008 Jan; 31(1):21-6. PubMed ID: 18054465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.